{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T02:58:12Z","timestamp":1784343492683,"version":"3.55.0"},"reference-count":58,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"unspecified","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2024,11,4]]},"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Diabetes mellitus (DM) is increasingly recognized as a possible consequence of statin therapy. Secondary analysis of randomized clinical trials and limited observational cohort analyses have suggested that women may be more likely than men to experience statin-associated DM. No analyses of real-world drug safety data addressing this question have been published.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Research design and methods<\/jats:title>\n                    <jats:p>This was a retrospective pharmacovigilance analysis of spontaneously reported adverse drug events (ADEs) submitted to the Food and Drug Administration Adverse Event Reporting System between January 1997 through December 2023. We analyzed cases that mentioned atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, or simvastatin in aggregate as well as cases reporting atorvastatin, pravastatin, rosuvastatin, simvastatin individually. DM events were identified using the Medical Dictionary for Regulatory Activities. We used the proportional reporting ratio to identify increased rates of statin-associated DM events in women and men compared with all other medications, and the reporting OR to compare reporting rates in women versus men.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 18,294,814 ADEs were reported during the study period. Among statin-associated ADEs, 14,874\/519,209 (2.9%) reports mentioned DM in women compared with 7,411\/489,453 (1.5%) in men, which were both significantly higher than background (0.6%). Statins were the primary-suspected or secondary-suspected cause of the ADE significantly more often in women than men (60 vs 30%), and reporting rates were disproportionately higher in women than in men for all statins. (reporting OR 1.9 (95% CI 1.9 to 2.0)). The largest difference in reporting of statin-associated DM between women and women was observed with atorvastatin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Analysis of post-marketing spontaneous ADE reports demonstrated a higher reporting rate of DM-associated with statin use compared with other medications with a significantly higher reporting rate in women compared with men. Future studies should consider mechanisms of statin-associated DM moderated by sex.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjdrc-2024-004343","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T21:45:18Z","timestamp":1733435118000},"page":"e004343","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Sex-differences in reporting of statin-associated diabetes mellitus to the US Food and Drug Administration"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2832-9348","authenticated-orcid":false,"given":"David P","family":"Kao","sequence":"first","affiliation":[{"name":"Colorado Center for Personalized Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"},{"name":"Ludeman Family Center for Women's Health Research, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"},{"name":"Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L","family":"Martin","sequence":"additional","affiliation":[{"name":"Colorado Center for Personalized Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"},{"name":"Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina L","family":"Aquilante","sequence":"additional","affiliation":[{"name":"Colorado Center for Personalized Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"},{"name":"Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise L","family":"Shalowitz","sequence":"additional","affiliation":[{"name":"Colorado Center for Personalized Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Leyba","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Kudron","sequence":"additional","affiliation":[{"name":"Colorado Center for Personalized Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"},{"name":"Department of Medicine, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8620-1003","authenticated-orcid":false,"given":"Jane E B","family":"Reusch","sequence":"additional","affiliation":[{"name":"Ludeman Family Center for Women's Health Research, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"},{"name":"Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith G","family":"Regensteiner","sequence":"additional","affiliation":[{"name":"Ludeman Family Center for Women's Health Research, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"},{"name":"Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"},{"name":"Department of Medicine, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"key":"2025073113150216000_12.6.e004343.1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-020-2338-1","article-title":"Repositioning of the global epicentre of non-optimal cholesterol","volume":"582","author":"Taddei","year":"2020","journal-title":"Nature New Biol"},{"key":"2025073113150216000_12.6.e004343.2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jsps.2023.04.002","article-title":"Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC\/AHA guidelines","volume":"31","author":"Matyori","year":"2023","journal-title":"Saudi Pharm J"},{"key":"2025073113150216000_12.6.e004343.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2014.10.025"},{"key":"2025073113150216000_12.6.e004343.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.02.032"},{"key":"2025073113150216000_12.6.e004343.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.02.018"},{"key":"2025073113150216000_12.6.e004343.6","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174\u2008000 participants in 27 randomised trials","volume":"385","author":"Fulcher","year":"2015","journal-title":"The Lancet"},{"key":"2025073113150216000_12.6.e004343.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.09.041"},{"key":"2025073113150216000_12.6.e004343.8","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.625"},{"key":"2025073113150216000_12.6.e004343.9","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-0738"},{"key":"2025073113150216000_12.6.e004343.10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.17925\/EE.2022.18.2.96","article-title":"Assessing the Incidence of New-onset Diabetes Mellitus with Statin Use: A Systematic Review of the Systematic Reviews and Meta-analyses","volume":"18","author":"Singh","year":"2022","journal-title":"touchREV Endocrinol"},{"key":"2025073113150216000_12.6.e004343.11","unstructured":"Centers for Disease Control . 30. Statins and diabetes: what you should know. Reports and Publications; 2023. Available: https:\/\/www.cdc.gov\/diabetes\/library\/features\/Statins_Diabetes.html"},{"key":"2025073113150216000_12.6.e004343.12","unstructured":"US Food and Drug Administration . OpenFDA: fda adverse event reporting system. Available: https:\/\/open.fda.gov\/data\/faers\/ [Accessed 21 Sep 2023]."},{"key":"2025073113150216000_12.6.e004343.13","unstructured":"Drugs@FDA data files. 2011. Available: http:\/\/www.fda.gov\/Drugs\/InformationOnDrugs\/ucm079750.htm"},{"key":"2025073113150216000_12.6.e004343.14","doi-asserted-by":"publisher","DOI":"10.1002\/pds.668"},{"key":"2025073113150216000_12.6.e004343.15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","article-title":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports","volume":"10","author":"Evans","year":"2001","journal-title":"Pharmacoepidemiology and Drug"},{"key":"2025073113150216000_12.6.e004343.16","doi-asserted-by":"crossref","unstructured":"Yu Y , Chen J , Li D , et al . Systematic Analysis of Adverse Event Reports for Sex Differences in Adverse Drug Events. Sci Rep 2016;6. doi:10.1038\/srep24955","DOI":"10.1038\/srep24955"},{"key":"2025073113150216000_12.6.e004343.17","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001184"},{"key":"2025073113150216000_12.6.e004343.18","doi-asserted-by":"crossref","unstructured":"Lin Y , Wang S , Li Z , et al . Short-Term Statin Therapy Induces Hepatic Insulin Resistance Through HNF4\u03b1\/PAQR9\/PPM1\u03b1 Axis Regulated AKT Phosphorylation. Adv Sci 2024. doi:10.1002\/ADVS.202403451","DOI":"10.1002\/advs.202403451"},{"key":"2025073113150216000_12.6.e004343.19","doi-asserted-by":"crossref","first-page":"155795","DOI":"10.1016\/j.metabol.2024.155795","article-title":"Dysregulation of autophagy activation induced by atorvastatin contributes to new-onset diabetes mellitus in western diet-fed mice","volume":"153","author":"Kim","year":"2024","journal-title":"Metab Clin Exp"},{"key":"2025073113150216000_12.6.e004343.20","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3528-5"},{"key":"2025073113150216000_12.6.e004343.21","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.3.357"},{"key":"2025073113150216000_12.6.e004343.22","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1239335","article-title":"Statins and risk of type 2 diabetes: mechanism and clinical implications","volume":"14","author":"Laakso","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025073113150216000_12.6.e004343.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061894"},{"key":"2025073113150216000_12.6.e004343.24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","article-title":"Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial","volume":"380","author":"Ridker","year":"2012","journal-title":"The Lancet"},{"key":"2025073113150216000_12.6.e004343.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11600-X"},{"key":"2025073113150216000_12.6.e004343.26","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","article-title":"MRC\/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial","volume":"361","year":"2003","journal-title":"The Lancet"},{"key":"2025073113150216000_12.6.e004343.27","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.10.2713"},{"key":"2025073113150216000_12.6.e004343.28","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","article-title":"Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial\u2014Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial","volume":"361","author":"Sever","year":"2003","journal-title":"The Lancet"},{"key":"2025073113150216000_12.6.e004343.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706201"},{"key":"2025073113150216000_12.6.e004343.30","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-0490"},{"key":"2025073113150216000_12.6.e004343.31","doi-asserted-by":"crossref","unstructured":"Anelli V , Armeni E , Paschou SA , et al . Statin use and incident type 2 diabetes mellitus in women after menopause. Maturitas 2024;181. doi:10.1016\/j.maturitas.2024.107914","DOI":"10.1016\/j.maturitas.2024.107914"},{"key":"2025073113150216000_12.6.e004343.32","doi-asserted-by":"publisher","DOI":"10.1089\/JWH.2007.0443"},{"key":"2025073113150216000_12.6.e004343.33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.therap.2022.10.002","article-title":"Sex differences in adverse drug reactions: Are women more impacted?","volume":"78","author":"Lacroix","year":"2023","journal-title":"Therapie"},{"key":"2025073113150216000_12.6.e004343.34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-2011.2010.00050.x"},{"key":"2025073113150216000_12.6.e004343.35","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-022-03332-z"},{"key":"2025073113150216000_12.6.e004343.36","doi-asserted-by":"publisher","DOI":"10.1007\/S00228-018-2480-Y\/TABLES\/10"},{"key":"2025073113150216000_12.6.e004343.37","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-015-0387-4"},{"key":"2025073113150216000_12.6.e004343.38","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13923"},{"key":"2025073113150216000_12.6.e004343.39","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.8224","article-title":"Sex Differences in Reported Adverse Drug Reactions to Angiotensin-Converting Enzyme Inhibitors","volume":"5","author":"Bots","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2025073113150216000_12.6.e004343.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2019.01.009"},{"key":"2025073113150216000_12.6.e004343.41","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4155"},{"key":"2025073113150216000_12.6.e004343.42","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000625"},{"key":"2025073113150216000_12.6.e004343.43","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.numecd.2012.03.003","article-title":"Comparison of the effects of different statins and doses on lipid levels in patients with diabetes: results from VOYAGER","volume":"22","author":"Karlson","year":"2012","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2025073113150216000_12.6.e004343.44","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)02599-7"},{"key":"2025073113150216000_12.6.e004343.45","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s13318-014-0211-z","article-title":"Pharmacokinetic study of rosuvastatin in males and females","volume":"40","author":"Nazir","year":"2015","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"2025073113150216000_12.6.e004343.46","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.atherosclerosis.2017.08.014","article-title":"Effects of age, gender and statin dose on lipid levels: Results from the VOYAGER meta-analysis database","volume":"265","author":"Karlson","year":"2017","journal-title":"Atherosclerosis"},{"key":"2025073113150216000_12.6.e004343.47","doi-asserted-by":"publisher","DOI":"10.1177\/106002809302700902"},{"key":"2025073113150216000_12.6.e004343.48","first-page":"47","article-title":"The gender-specific clinical pharmacology of statins: an update","volume":"4","author":"Cignarella","year":"2018","journal-title":"Ital J Gender-Spec Med"},{"key":"2025073113150216000_12.6.e004343.49","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00228-016-2105-2","article-title":"Statin-induced myopathy in a usual care setting-a prospective observational study of gender differences","volume":"72","author":"Skilving","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"key":"2025073113150216000_12.6.e004343.50","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jacl.2016.02.016","article-title":"Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study","volume":"10","author":"Karalis","year":"2016","journal-title":"J Clin Lipidol"},{"key":"2025073113150216000_12.6.e004343.51","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000028394","article-title":"Sex disparities in the effect of statins on lipid parameters: The PharmLines Initiative","volume":"101","author":"Hunt","year":"2022","journal-title":"Medicine (Balt)"},{"key":"2025073113150216000_12.6.e004343.52","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.860"},{"key":"2025073113150216000_12.6.e004343.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.04.005"},{"key":"2025073113150216000_12.6.e004343.54","doi-asserted-by":"crossref","unstructured":"Djouss\u00e9 L , Song RJ , Cho K , et al . Association of statin therapy with incidence of type 2 diabetes among US Veterans. J Clin Cardiol Cardiovasc Ther 2019;1. doi:10.31546\/JCCCVT.1002","DOI":"10.31546\/JCCCVT.1002"},{"key":"2025073113150216000_12.6.e004343.55","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"The Lancet"},{"key":"2025073113150216000_12.6.e004343.56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195459","article-title":"Risk of new-onset diabetes among patients treated with statins according to hypertension and gender: Results from a nationwide health-screening cohort","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS One"},{"key":"2025073113150216000_12.6.e004343.57","doi-asserted-by":"crossref","unstructured":"li H , lin H , Zhao H . Statins use and risk of new-onset diabetes in hypertensive patients: a population-based retrospective cohort study in Yinzhou district, Ningbo city, People\u2019s Republic of China. Ther Clin Risk Manag 2018;14. doi:10.2147\/TCRM.S158850","DOI":"10.2147\/TCRM.S158850"},{"key":"2025073113150216000_12.6.e004343.58","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.29074","article-title":"Adverse Drug Events by Sex After Adjusting for Baseline Rates of Drug Use","volume":"6","author":"Rushovich","year":"2023","journal-title":"JAMA Netw Open"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2024-004343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T20:15:13Z","timestamp":1753992913000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2024-004343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":58,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,12,5]]},"published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1136\/bmjdrc-2024-004343"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2024-004343","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.05.01.24306727","asserted-by":"object"}]},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}